Published in Int J Food Microbiol on October 15, 2003
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
Rapid and sensitive detection of noroviruses by using TaqMan-based one-step reverse transcription-PCR assays and application to naturally contaminated shellfish samples. Appl Environ Microbiol (2005) 1.72
Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63
Detection of multiple noroviruses associated with an international gastroenteritis outbreak linked to oyster consumption. J Clin Microbiol (2006) 1.56
Aichi virus, norovirus, astrovirus, enterovirus, and rotavirus involved in clinical cases from a French oyster-related gastroenteritis outbreak. J Clin Microbiol (2008) 1.50
Noroviruses - State of the Art. Food Environ Virol (2010) 1.39
Detection and quantification of noroviruses in shellfish. Appl Environ Microbiol (2008) 1.16
Distribution in tissue and seasonal variation of norovirus genogroup I and II ligands in oysters. Appl Environ Microbiol (2010) 1.05
Transmission of viruses through shellfish: when specific ligands come into play. Curr Opin Virol (2011) 1.02
Inactivation of enteric viruses in minimally processed berries and herbs. Appl Environ Microbiol (2009) 1.00
Bioaccumulation, retention, and depuration of enteric viruses by Crassostrea virginica and Crassostrea ariakensis oysters. Appl Environ Microbiol (2008) 0.96
Use of rotavirus virus-like particles as surrogates to evaluate virus persistence in shellfish. Appl Environ Microbiol (2005) 0.94
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet (2004) 5.25
Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09
Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41
Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med (2002) 3.86
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83
Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) (2002) 2.75
Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.59
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
Noroviruses everywhere: has something changed? Curr Opin Infect Dis (2006) 2.44
Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis (2006) 2.43
The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.43
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
Evaluation of removal of noroviruses during wastewater treatment, using real-time reverse transcription-PCR: different behaviors of genogroups I and II. Appl Environ Microbiol (2007) 1.85
Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect (2005) 1.83
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine (2003) 1.83
Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73
Molecular characterisation and phylogenetic analysis of Chronic bee paralysis virus, a honey bee virus. Virus Res (2008) 1.72
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2010) 1.69
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med (2006) 1.68
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J Acquir Immune Defic Syndr (2005) 1.63
Helical prospective ECG-gating in cardiac computed tomography: radiation dose and image quality. Int J Cardiovasc Imaging (2009) 1.58
Detection of multiple noroviruses associated with an international gastroenteritis outbreak linked to oyster consumption. J Clin Microbiol (2006) 1.56
Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
Aichi virus, norovirus, astrovirus, enterovirus, and rotavirus involved in clinical cases from a French oyster-related gastroenteritis outbreak. J Clin Microbiol (2008) 1.50
Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49
Virus diversity in a winter epidemic of acute diarrhea in France. J Clin Microbiol (2002) 1.48
Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis (2013) 1.46
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine (2009) 1.44
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40
Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis (2007) 1.34
Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis (2007) 1.33
Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol (2004) 1.32
Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis (2008) 1.32
Strain-dependent norovirus bioaccumulation in oysters. Appl Environ Microbiol (2011) 1.32
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients. Antimicrob Agents Chemother (2005) 1.30
Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio (2012) 1.27
Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23
Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas. J Clin Microbiol (2007) 1.23
Detection of noroviruses in raspberries associated with a gastroenteritis outbreak. Int J Food Microbiol (2004) 1.20
Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20
Comprehensive analysis of a norovirus-associated gastroenteritis outbreak, from the environment to the consumer. J Clin Microbiol (2010) 1.20
Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults. J Virol (2002) 1.17
Detection and quantification of noroviruses in shellfish. Appl Environ Microbiol (2008) 1.16
Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One (2012) 1.13
Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol (2003) 1.12
European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples. Clin Vaccine Immunol (2007) 1.11
Human and animal enteric caliciviruses in oysters from different coastal regions of the United States. Appl Environ Microbiol (2006) 1.11
Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitors. Ann Pharmacother (2005) 1.11
Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol (2011) 1.10
Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. J Infect (2007) 1.10
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine (2009) 1.07
Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults. Clin Infect Dis (2011) 1.05
Distribution in tissue and seasonal variation of norovirus genogroup I and II ligands in oysters. Appl Environ Microbiol (2010) 1.05
Norovirus vaccine development: next steps. Expert Rev Vaccines (2012) 1.03
Environmental detection of genogroup I, II, and IV noroviruses by using a generic real-time reverse transcription-PCR assay. Appl Environ Microbiol (2013) 1.02
Transmission of viruses through shellfish: when specific ligands come into play. Curr Opin Virol (2011) 1.02
Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA. J Infect (2008) 1.02
Epidemiology of rotavirus infection among young children with acute diarrhoea in Burkina Faso. BMC Pediatr (2010) 1.01
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. Vaccine (2012) 0.99
Preparing for a possible pandemic: influenza A/H5N1 vaccine development. Curr Opin Pharmacol (2007) 0.99
A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route. Vaccine (2009) 0.98
Detection of cytotoxin-hemolysin mRNA in nonculturable populations of environmental and clinical Vibrio vulnificus strains in artificial seawater. Appl Environ Microbiol (2002) 0.97
Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans. PLoS One (2012) 0.97
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge. J Virol (2011) 0.97
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol (2012) 0.97
Inactivated influenza vaccination for people with spinal cord injury. Arch Phys Med Rehabil (2004) 0.96
Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor alpha4beta7. Virology (2003) 0.95
Recovery in culture of viable but nonculturable Vibrio parahaemolyticus: regrowth or resuscitation? ISME J (2007) 0.94
Use of rotavirus virus-like particles as surrogates to evaluate virus persistence in shellfish. Appl Environ Microbiol (2005) 0.94
Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France. J Clin Microbiol (2003) 0.93
Uncommon(ly considered) manifestations of infection with rhinovirus, agent of the common cold. Clin Infect Dis (2005) 0.92
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol (2010) 0.92
Real-time reverse transcription-PCR for transcriptional expression analysis of virulence and housekeeping genes in viable but nonculturable Vibrio parahaemolyticus after recovery of culturability. Appl Environ Microbiol (2007) 0.92
Detection of human caliciviruses in fecal samples by rt-PCR. Methods Mol Biol (2011) 0.91
The mycobacterial DNA-binding protein 1 (MDP1) from Mycobacterium bovis BCG influences various growth characteristics. BMC Microbiol (2008) 0.91
Bovine norovirus: carbohydrate ligand, environmental contamination, and potential cross-species transmission via oysters. Appl Environ Microbiol (2010) 0.90
Molecular characterization of isolates of waterborne Cryptosporidium spp. collected during an outbreak of gastroenteritis in South Burgundy, France. J Clin Microbiol (2003) 0.90